Overview

A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients

Status:
Completed
Trial end date:
2018-03-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate effects of BMS-986165 on blood levels of methotrexate given as a single dose in healthy male patients.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
BMS-986165
Leucovorin
Methotrexate